The prolongation of QTc-interval by thioridazine

被引：4
|
作者：
Sachdev, P
机构：
来源：
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY | 2001年 / 35卷 / 06期
关键词：
D O I：
10.1046/j.1440-1614.2001.0971g.x
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：857 / 858
页数：2
相关论文
共 50 条
  • [1] Information on QTc-Interval Prolongation in the Summary of Product Characteristics
    Warnier, Miriam J.
    Holtkamp, Frank A.
    Rutten, Frans H.
    Hoes, Arno W.
    de Boer, Anthonius
    Mol, Peter G. M.
    De Bruin, Marie L.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 248 - 249
  • [2] Ventricular Ectopy and QTc-Interval Prolongation Associated with Dronedarone Therapy
    Gonzalez, Jaime E.
    Sauer, William H.
    Krantz, Mori J.
    [J]. PHARMACOTHERAPY, 2013, 33 (10): : E179 - E181
  • [3] EVALUATION OF AZITHROMYCIN ADMINISTRATION AND QTC-INTERVAL PROLONGATION IN THE CRITICALLY ILL
    Fiorvento, Anna
    Park, Linda
    Al Shelli, Ihab
    Mostafa, Ashraf
    Pusnik, Maria
    [J]. CRITICAL CARE MEDICINE, 2015, 43 (12)
  • [4] Is QTc-Interval Prolongation an Inherent Feature of Eating Disorders? A Cohort Study
    Krantz, Mori J.
    Blalock, Dan V.
    Tanganyika, Kundai
    Farasat, Morteza
    McBride, Jennifer
    Mehler, Philip S.
    [J]. AMERICAN JOURNAL OF MEDICINE, 2020, 133 (09): : 1088 - +
  • [5] Incidence and relevance of QTc-interval prolongation caused by tyrosine kinase inhibitors
    J S L Kloth
    A Pagani
    M C Verboom
    A Malovini
    C Napolitano
    W H J Kruit
    S Sleijfer
    N Steeghs
    A Zambelli
    R H J Mathijssen
    [J]. British Journal of Cancer, 2015, 112 : 1011 - 1016
  • [6] Incidence and relevance of QTc-interval prolongation caused by tyrosine kinase inhibitors
    Kloth, J. S. L.
    Pagani, A.
    Verboom, M. C.
    Malovini, A.
    Napolitano, C.
    Kruit, W. H. J.
    Sleijfer, S.
    Steeghs, N.
    Zambelli, A.
    Mathijssen, R. H. J.
    [J]. BRITISH JOURNAL OF CANCER, 2015, 112 (06) : 1011 - 1016
  • [7] An evaluation of factors associated with QTc-Interval prolongation in patients receiving propofol.
    Scalese, Michael
    Herring, Holly
    Rathbun, R. Chris
    Skrepnek, Grant
    Ripley, Toni
    [J]. PHARMACOTHERAPY, 2014, 34 (10): : E186 - E186
  • [8] The risk of QTc-interval prolongation in COVID-19 patients treated with chloroquine
    Sinkeler, F. S.
    Berger, F. A.
    Muntinga, H. J.
    Jansen, M. M. P. M.
    [J]. NETHERLANDS HEART JOURNAL, 2020, 28 (7-8) : 418 - 423
  • [9] QTc-interval prolongation and increased risk of sudden cardiac death associated with hydroxychloroquine
    Ahmadizar, Fariba
    Soroush, Negin
    Ikram, M. Arfan
    Kors, Jan A.
    Kavousi, Maryam
    Stricker, Bruno H.
    [J]. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2022, 28 (17) : 1875 - 1882
  • [10] The risk of QTc-interval prolongation in COVID-19 patients treated with chloroquine
    F. S. Sinkeler
    F. A. Berger
    H. J. Muntinga
    M. M. P. M. Jansen
    [J]. Netherlands Heart Journal, 2020, 28 : 418 - 423
12345